Safety and caution characterize the next frontier of Rx-to-OTC switches
Companies are being more selective in the Rx-to-OTC switches they pursue, according to new research just published by Kline & Company in the 13th study in its venerable syndicated series, Rx-to-OTC Switch Forecasts USA: Next Frontier. Safety is paramount, and the sophistication of clinical studies required to gain approval has increased the cost burden and